We are analyzing https://link.springer.com/article/10.1007/s10753-022-01689-y.

Title:
Resveratrol Ameliorates Deep Vein Thrombosis-Induced Inflammatory Response Through Inhibiting HIF-1α/NLRP3 Pathway | Inflammation
Description:
Deep vein thrombosis (DVT) has become a prevalent and increasingly serious problem globally and resveratrol (Res) is a natural antitoxin that inhibits arterial thrombosis. To investigate the effect of Res on DVT and further explore its mechanism, thrombosis was monitored at different time points and the pathological changes occurring in the inferior vena cava (IVC) and lung tissue were observed in Sprague–Dawley rats. The protein expression of HIF-1α and NLRP3 in the IVC and lung tissue and the concentrations of D-dimer (D2D), prothrombin fragment 1 + 2 (F1 + 2), interleukin-1β (IL-1β), caspase-1, and tissue factor (TF) in the plasma were determined. After setting different doses of Res groups and using low-molecular-weight heparin (LMWH) as a positive control to determine the effective experimental dose of Res, rats were further divided into sham, DVT, HIF-1α inhibitor, Res, and HIF-1α inhibitor + Res groups. The above indicators were tested repeatedly. The DVT was formed on the 1st day of modeling. With the extension of time, DVT was gradually institutionalized and finally recanalized. Lesions in the IVC and lung tissue were effectively ameliorated, and thrombosis was significantly decreased in the LMWH or 60 mg/kg Res-treated groups. The levels of D2D, F1 + 2, IL-1β, caspase-1, TF, and the expression of HIF-1α and NLRP3 were significantly reduced in the HIF-1α inhibitor, Res, and HIF-1α inhibitor + Res groups. Res can ameliorate DVT in rats by inhibiting HIF-1α/NLRP3 pathway, which provides a novel therapeutic strategy for DVT treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, pubmed, google, scholar, thrombosis, cas, journal, central, deep, liu, vein, zhang, wang, res, hifα, dvt, resveratrol, pathway, access, authors, content, data, inflammation, manuscript, jiang, nlrp, venous, chen, privacy, cookies, research, inhibiting, hifαnlrp, published, fei, qin, han, tissue, heparin, information, publish, search, inflammatory, response, jianwen, xiao, junjie, lung, rats, expression,

Topics {✒️}

hypoxia-inducible factor-1α/cyclo-oxygenase-2 pathway long-term low-molecular-weight heparin inferior vena cava mediates nlrp3 inflammasome-dependent-pyroptotic low-molecular-weight heparin inhibiting hif-1α/nlrp3 pathway 60 mg/kg res-treated groups nlrp3/caspase-1/il-1β pathway hif-1α inhibitor + res groups month download article/chapter hypoxia-inducible factor 1α hypoxia inducible factor-1α article inflammation aims mir-135b protects cardiomyocytes deep vein thrombosis inflammatory bowel disease key research related subjects hif-1α inhibitor hif-1α expression full article pdf deep venous thrombosis privacy choices/manage cookies nlrp3-inflammasome activation inhibits arterial thrombosis nuclear factor-κb animal ethics committee world thrombosis day published article check access instant access european economic area valls-de-souza post-thrombotic syndrome percutaneous mechanical thrombectomy recurrent spontaneous abortion /akt/mammalian target eugene paul cosky apoptotic cell death isth steering committee global disease burden acanthopanax senticosus polysaccharides lipopolysaccharide-challenged piglets hif-1α article fei conditions privacy policy nlrp3 inflammasome vegf/flt-1 signaling effective experimental dose improves peritoneal function

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Resveratrol Ameliorates Deep Vein Thrombosis-Induced Inflammatory Response Through Inhibiting HIF-1α/NLRP3 Pathway
         description:Deep vein thrombosis (DVT) has become a prevalent and increasingly serious problem globally and resveratrol (Res) is a natural antitoxin that inhibits arterial thrombosis. To investigate the effect of Res on DVT and further explore its mechanism, thrombosis was monitored at different time points and the pathological changes occurring in the inferior vena cava (IVC) and lung tissue were observed in Sprague–Dawley rats. The protein expression of HIF-1α and NLRP3 in the IVC and lung tissue and the concentrations of D-dimer (D2D), prothrombin fragment 1 + 2 (F1 + 2), interleukin-1β (IL-1β), caspase-1, and tissue factor (TF) in the plasma were determined. After setting different doses of Res groups and using low-molecular-weight heparin (LMWH) as a positive control to determine the effective experimental dose of Res, rats were further divided into sham, DVT, HIF-1α inhibitor, Res, and HIF-1α inhibitor + Res groups. The above indicators were tested repeatedly. The DVT was formed on the 1st day of modeling. With the extension of time, DVT was gradually institutionalized and finally recanalized. Lesions in the IVC and lung tissue were effectively ameliorated, and thrombosis was significantly decreased in the LMWH or 60 mg/kg Res-treated groups. The levels of D2D, F1 + 2, IL-1β, caspase-1, TF, and the expression of HIF-1α and NLRP3 were significantly reduced in the HIF-1α inhibitor, Res, and HIF-1α inhibitor + Res groups. Res can ameliorate DVT in rats by inhibiting HIF-1α/NLRP3 pathway, which provides a novel therapeutic strategy for DVT treatment.
         datePublished:2022-06-02T00:00:00Z
         dateModified:2022-06-02T00:00:00Z
         pageStart:2268
         pageEnd:2279
         sameAs:https://doi.org/10.1007/s10753-022-01689-y
         keywords:
            Inflammation
            HIF-1α/NLRP3
            Inferior vena cava
            Lung
            Plasma
            Immunology
            Rheumatology
            Pharmacology/Toxicology
            Pathology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig7_HTML.jpg
         isPartOf:
            name:Inflammation
            issn:
               1573-2576
               0360-3997
            volumeNumber:45
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jianwen Fei
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiao Qin
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hongfu Ma
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xuefeng Zhang
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Haixia Wang
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jin Han
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chaoxiao Yu
               affiliation:
                     name:Yantaishan Hospital
                     address:
                        name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junjie Jiang
               url:http://orcid.org/0000-0003-0636-9629
               affiliation:
                     name:Yantaishan Hospital, Laishan District
                     address:
                        name:Department of Orthopedics, Yantaishan Hospital, Laishan District, Yantai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Resveratrol Ameliorates Deep Vein Thrombosis-Induced Inflammatory Response Through Inhibiting HIF-1α/NLRP3 Pathway
      description:Deep vein thrombosis (DVT) has become a prevalent and increasingly serious problem globally and resveratrol (Res) is a natural antitoxin that inhibits arterial thrombosis. To investigate the effect of Res on DVT and further explore its mechanism, thrombosis was monitored at different time points and the pathological changes occurring in the inferior vena cava (IVC) and lung tissue were observed in Sprague–Dawley rats. The protein expression of HIF-1α and NLRP3 in the IVC and lung tissue and the concentrations of D-dimer (D2D), prothrombin fragment 1 + 2 (F1 + 2), interleukin-1β (IL-1β), caspase-1, and tissue factor (TF) in the plasma were determined. After setting different doses of Res groups and using low-molecular-weight heparin (LMWH) as a positive control to determine the effective experimental dose of Res, rats were further divided into sham, DVT, HIF-1α inhibitor, Res, and HIF-1α inhibitor + Res groups. The above indicators were tested repeatedly. The DVT was formed on the 1st day of modeling. With the extension of time, DVT was gradually institutionalized and finally recanalized. Lesions in the IVC and lung tissue were effectively ameliorated, and thrombosis was significantly decreased in the LMWH or 60 mg/kg Res-treated groups. The levels of D2D, F1 + 2, IL-1β, caspase-1, TF, and the expression of HIF-1α and NLRP3 were significantly reduced in the HIF-1α inhibitor, Res, and HIF-1α inhibitor + Res groups. Res can ameliorate DVT in rats by inhibiting HIF-1α/NLRP3 pathway, which provides a novel therapeutic strategy for DVT treatment.
      datePublished:2022-06-02T00:00:00Z
      dateModified:2022-06-02T00:00:00Z
      pageStart:2268
      pageEnd:2279
      sameAs:https://doi.org/10.1007/s10753-022-01689-y
      keywords:
         Inflammation
         HIF-1α/NLRP3
         Inferior vena cava
         Lung
         Plasma
         Immunology
         Rheumatology
         Pharmacology/Toxicology
         Pathology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-022-01689-y/MediaObjects/10753_2022_1689_Fig7_HTML.jpg
      isPartOf:
         name:Inflammation
         issn:
            1573-2576
            0360-3997
         volumeNumber:45
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jianwen Fei
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiao Qin
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hongfu Ma
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xuefeng Zhang
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Haixia Wang
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jin Han
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chaoxiao Yu
            affiliation:
                  name:Yantaishan Hospital
                  address:
                     name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junjie Jiang
            url:http://orcid.org/0000-0003-0636-9629
            affiliation:
                  name:Yantaishan Hospital, Laishan District
                  address:
                     name:Department of Orthopedics, Yantaishan Hospital, Laishan District, Yantai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Inflammation
      issn:
         1573-2576
         0360-3997
      volumeNumber:45
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital
      address:
         name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
         type:PostalAddress
      name:Yantaishan Hospital, Laishan District
      address:
         name:Department of Orthopedics, Yantaishan Hospital, Laishan District, Yantai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jianwen Fei
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Xiao Qin
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Hongfu Ma
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Xuefeng Zhang
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Haixia Wang
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Jin Han
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Chaoxiao Yu
      affiliation:
            name:Yantaishan Hospital
            address:
               name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
               type:PostalAddress
            type:Organization
      name:Junjie Jiang
      url:http://orcid.org/0000-0003-0636-9629
      affiliation:
            name:Yantaishan Hospital, Laishan District
            address:
               name:Department of Orthopedics, Yantaishan Hospital, Laishan District, Yantai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Pulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China
      name:Department of Orthopedics, Yantaishan Hospital, Laishan District, Yantai, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(128)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.4s.

LINK . SPRINGER . COM {}